Cannabis Science Inc. (OTCMKTS:CBIS) Shares Jump on $55M Crown Baus Investment Confirmation

3755

Cannabis Science Inc. (OTCMKTS:CBIS) received a boost in early trading today on the heels of an announcement pertaining to a previously speculative deal with Crown Baus Capital Corp (OTCMKTS:CBCA). It has been confirmed just this morning that the deal will go forward.

We feel this development warrants serious consideration as a reason for keeping a very careful eye on CBIS stock in the days and weeks ahead. As we’ll highlight in just a minute, the deal brings a significant chunk of equity assets to the table for CBIS, to the tune of $55M worth of stock.

Even prior to any official word on the deal between Cannabis Science Inc. (OTCMKTS:CBIS) and Crown Baus, 2017 was already shaping up very well for CBIS. Shares were changing hands for as little as .06 at the beginning of the new calendar year, and just over a month later, at the beginning of this week, reached .13, representing a 116% upswing.

Cannabis Science’s Landmark Agreement with Crown Baus

Crown Baus Capital Corp. announced today it had acquired 100-acre investment participation in the Cannabis Science Property and Drug Development Projects spread across California and Nevada. The agreement includes cultivation, laboratory, and manufacturing capabilities. CBIS will receive 10 million common shares of CBCA as payment in kind. Raymond Dabney is the President, CEO, and Co-Founder of both CBCA and CBIS.

Under the terms of the agreement between CBCA and CBIS, CBCA has acquired the rights to 100-acre property and drug development investments spread across California and Nevada with CBIS. CBCA will finance and begin the buildout of its pilot immediately, approximately 33,000 sq. ft. in the Cannabis Science, Inc. (CBIS) Property and Drug Development Project in Douglas County, Nevada. CBCA reserves the right to invest or bring in additional investment partners for the buildout of the additional acres. CBCA is a global acquisition-based conglomerate targeting opportunities in Drug Development, High-tech Incubation, Entertainment & Media, Education, and Financial Services.

CBCA’s President, CEO, and Co-Founder, Mr. Raymond C. Dabney, stated, “I am excited to announce our agreement with CBIS. That’s 66,000 sq. ft. we will be building out with CBIS & CBCA over this spring and summer. We are certainly looking to bring that number well over 100,000 sq. ft. over the coming months. In line with CBCA’s growth strategy in one of our core areas, we see tremendous value in our Property and Drug Development Projects. Each one-acre parcel provides investors with 33,000 square feet of space to build fully-licensed and state compliant medical cannabis and/or industrial hemp production facilities.”

This agreement more closely aligns the interests of CBCA and CBIS in Drug Development and will enable each company to focus on its particular area of expertise. “I expect the shareholders of CBCA and CBIS to see increased value as a direct result of this agreement. Particularly, this relationship will allow CBIS to focus on drug development and will allow CBCA to focus on finance, as well as on future acquisition deals,” stated Mr. Dabney.

CBCA intends to utilize its investment management experience, working with CBIS, to finance some of the CBIS projects in California and Nevada beginning with the Douglas County, Nevada Property and Drug Development Project. This project will serve as a model for similar projects that can be developed in a number of states throughout the U.S. In addition to creating large-scale 250,000+ sq. ft. manufacturing and cultivation opportunities for CBCA’s investment partners, each project is expected to create a significant number of jobs in the construction, farming, retail, and education industries. CBIS currently has access to over 10,000,000 square feet of property that can be used for fully-licensed large-scale drug development grow and production operations.

(Source: Marketwired)

 

What kind of an impact will such a large infusion of equity assets into CBIS’ portfolio have on an extended-term basis? Find out the answer to that question, and get loads of other news and updates on a multitude of marijuana stocks right here on Street Register! We’ve developed a keen affection for the cannabis sector that grows by leaps and bounds seemingly every day! Stay locked on StreetRegister.com, add us to your bookmarks, and be sure you’re signed up for our 100% free smallcap newsletter. Simply enter your primary active email address in the box below! Subscribe now!

1 COMMENT

LEAVE A REPLY